Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion type Assertion NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_head.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion description "[Notably, the early administration of Ad-IL4-MSCs in mice with EAE at the time of T-cell priming attenuated clinical disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_provenance.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion evidence source_evidence_literature NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_provenance.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion SIO_000772 22568986 NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_provenance.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion wasDerivedFrom befree-20150227 NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_provenance.
- NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_assertion wasGeneratedBy ECO_0000203 NP494786.RA0DdjtaJHshW2Kx7zyFz2qDRGhEJz2yZ2NE1eSJukwhk130_provenance.